Proventil HFA Inhalation Aerosol

Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Pulmonary/Respiratory Diseases
Areas: Respiratory

| General Information |

General Information

Proventil HFA Inhalation Aerosol (albuterol sulfate) Inhalation Aerosol covers a supplemental new drug application that provides for the following: lowering the age from 12 years to 4 years and older for the treatment or prevention of

bronchospasm with reversible obstructive airway disease
exercise-induced bronchospasm

< back to top

Proventil HFA Inhalation Aerosol Drug Information

The Proventil Hfa Inhalation Aerosol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.